The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 354:1203-1204 March 16, 2006 Number 11
NextNext

Oral Contraceptives in Women with Systemic Lupus Erythematosus

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Sánchez-Guerrero, J.
-Related Article
by Petri, M.
-PubMed Citation
To the Editor: As Petri et al. state (Dec. 15 issue),1 oral contraceptives are the most widely used form of reversible contraception. However, the most effective contraceptive is the intrauterine device (IUD). With a first-year failure rate of 0.1 percent, the levonorgestrel IUD is superior to sterilization2 and constitutes an excellent choice when pregnancy is dangerous. In the large trials of IUDs sponsored by the World Health Organization and cited by Sánchez-Guerrero et al. in the same issue of the Journal,3 the risk of upper genital tract infection was limited to the first 20 days after insertion.4 As such, . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.